Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (347)

1

HER2 and immunotherapy using monoclonal antibodies in colorectal cancer

enthalten in: Immunotherapy | 2013

von Nazemalhosseini Mojarad, E. | Kuppen, P.

2

Combined HER2 analysis of biopsies and surgical specimens to optimize detection of trastuzumab-eligible patients in eso-gastric adenocarcinoma : a GERCOR study

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2013

von Watson, S. | Validire, P. | Cervera, P. | +9

3

HER2 in high-risk rectal cancer patients treated in EXPERT-C, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximab

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2013

von Sclafani, F. | Roy, A. | Cunningham, D. | +9

4

Pattern of rash, diarrhea, and hepatic toxicities secondary to lapatinib and their association with age and response to neoadjuvant therapy : analysis from the NeoALTTO trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2013

von Azim, H. | Agbor-Tarh, D. | Bradbury, I. | +15

ErratumIn: J Clin Oncol. 2014 Feb 1;32(4):365

5

Clinical outcomes and cardiac safety of continuous antiHer2 therapy in c-erbB2-positive metastatic breast cancer patients

enthalten in: Journal of chemotherapy (Florence, Italy) | 2013

von Fedele, P. | Orlando, L. | Schiavone, P. | +10

6

Molecular determinants of trastuzumab efficacy : What is their clinical relevance?

enthalten in: Cancer treatment reviews | 2013

von De, P. | Hasmann, M. | Leyland-Jones, B.

7

A multicenter phase I-II study of docetaxel plus epirubicin plus bevacizumab as first-line treatment in women with HER2-negative metastatic breast cancer

enthalten in: Breast (Edinburgh, Scotland) | 2013

von Tryfonidis, K. | Boukovinas, I. | Xenidis, N. | +9

8

Evaluation of real-time immunohistochemistry and interaction map as an alternative objective assessment of HER2 expression in human breast cancer tissue

enthalten in: Applied immunohistochemistry & molecular morphology : AIMM | 2013

von Gedda, L. | Björkelund, H. | Lebel, L. | +6

9

Dual HER2 inhibition in combination with anti-VEGF treatment is active in heavily pretreated HER2-positive breast cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2013

von Falchook, G. | Moulder, S. | Wheler, J. | +3

10

Salivary duct carcinoma responding to trastuzumab-based therapy : case report and review of the literature

enthalten in: Head & neck | 2013

von Krishnamurthy, J. | Krishnamurty, D. | Baker, J. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[35]